MolecuLight Optimizes Burn Care with Advanced Bacterial Imaging at the American Burn Association 2025 Annual Meeting

"The ability to visualize bacteria in real-time with MolecuLight has far-reaching implications for improving burn wound reconstruction," says Dr. Erik Hanson-Viana. "By providing immediate, actionable information, MolecuLight has led to more precise interventions, ultimately improving reconstructive outcomes. My research also demonstrates the clear advantage of MolecuLight-targeted sampling over traditional methods, and I am thrilled to share these findings with my colleagues at the ABA meeting."

"The ability to visualize bacteria in real-time with MolecuLight has far-reaching implications for improving burn wound reconstruction," says Dr. Erik Hanson-Viana. "By providing immediate, actionable information, MolecuLight has led to more precise interventions, ultimately improving reconstructive outcomes. My research also demonstrates the clear advantage of MolecuLight-targeted sampling over traditional methods, and I am thrilled to share these findings with my colleagues at the ABA meeting."

About MolecuLight Inc:

MolecuLight Inc. is a privately owned medical imaging company with a global presence that manufactures and commercializes the MolecuLight i:X^® and DX^™ wound imaging devices. These are the only class II FDA-cleared point-of-care imaging devices for the real-time detection of elevated bacterial burden in wounds. They also provide accurate digital wound measurement for comprehensive wound management, supported by strong clinical evidence including over 100 peer-reviewed publications.

www.moleculight.com

Photo - https://mma.prnewswire.com/media/2659606/MolecuLight_MolecuLight_Optimizes_Burn_Care_with_Advanced_Bacter.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/moleculight-optimizes-burn-care-with-advanced-bacterial-imaging-at-the-american-burn-association-2025-annual-meeting-302422559.html